{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:08:07Z","timestamp":1770998887370,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1546-0096-11-16","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T06:53:36Z","timestamp":1366008816000},"source":"Crossref","is-referenced-by-count":84,"title":["Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-\u03b1 therapy in childhood chronic uveitis"],"prefix":"10.1186","volume":"11","author":[{"given":"Gabriele","family":"Simonini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Taddio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cattalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"de Libero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Parentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Pagnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Cimaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"key":"981_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1076\/ocii.8.4.251.6459","volume":"8","author":"ET Cunnigham","year":"2000","unstructured":"Cunnigham ET: Uveitis in children. Ocul Immunol Inflamm. 2000, 8: 251-261. 10.1076\/ocii.8.4.251.6459.","journal-title":"Ocul Immunol Inflamm"},{"key":"981_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/14728220902852570","volume":"18","author":"F Lyon","year":"2009","unstructured":"Lyon F, Gale RP, Lightman S: Recent developments in the treatment of uveitis: an update. Expert Opin Investig Drugs. 2009, 18: 609-616. 10.1517\/14728220902852570.","journal-title":"Expert Opin Investig Drugs"},{"key":"981_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","volume":"9","author":"G Simonini","year":"2010","unstructured":"Simonini G, Cantarini L, Lo Russo M: Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010, 9: 674-683. 10.1016\/j.autrev.2010.05.017.","journal-title":"Autoimmun Rev"},{"key":"981_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/IIO.0b013e31817d7107","volume":"48","author":"M Zierhut","year":"2008","unstructured":"Zierhut M, Doycheva D, Biester S, St\u00fcbiger N, K\u00fcmmerle-Deschner J, Deuter C: Therapy of uveitis in children. Int Ophthalmol Clin. 2008, 48: 131-152. 10.1097\/IIO.0b013e31817d7107.","journal-title":"Int Ophthalmol Clin"},{"key":"981_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","volume":"18","author":"FR Imrie","year":"2007","unstructured":"Imrie FR, Dick AD: Biologics in the treatment of uveitis. Curr Opin Ophthalmol. 2007, 18: 481-486. 10.1097\/ICU.0b013e3282f03d42.","journal-title":"Curr Opin Ophthalmol"},{"key":"981_CR6","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","volume":"45","author":"RK Saurenmann","year":"2006","unstructured":"Saurenmann RK, Levin AV, Rose JB: Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology. 2006, 45: 982-989. 10.1093\/rheumatology\/kel030.","journal-title":"Rheumatology"},{"key":"981_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","volume":"91","author":"MJ Gallagher","year":"2007","unstructured":"Gallagher MJ, Quinones K, Cervantes-Castaneds RA, Yilmaz T, Foster CS: Biologic response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007, 91: 1341-1344. 10.1136\/bjo.2007.124081.","journal-title":"Br J Ophthalmol"},{"key":"981_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2005.09.037","volume":"113","author":"RT Rajaraman","year":"2006","unstructured":"Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS: Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. 2006, 113: 308-314. 10.1016\/j.ophtha.2005.09.037.","journal-title":"Ophthalmology"},{"key":"981_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ajo.2007.08.018","volume":"144","author":"SP Ardoin","year":"2007","unstructured":"Ardoin SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ: Infliximab to treat chronic non infectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol. 2007, 144: 844-849. 10.1016\/j.ajo.2007.08.018.","journal-title":"Am J Ophthalmol"},{"key":"981_CR10","first-page":"819","volume":"127","author":"EB Suhler","year":"2009","unstructured":"Suhler EB, Smith JR, Giles TR: Infliximab Therapy for Refractory Uveitis: 2-Year results of a Prospective Trial. Arch Ophthalmol. 2009, 127: 819-822.","journal-title":"Arch Ophthalmol"},{"key":"981_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","volume":"47","author":"P Tynj\u00e4l\u00e4","year":"2008","unstructured":"Tynj\u00e4l\u00e4 P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, Lahdenne P: Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology. 2008, 47: 339-344.","journal-title":"Rheumatology"},{"key":"981_CR12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/ard.2006.058248","volume":"66","author":"P Tynjala","year":"2007","unstructured":"Tynjala P, Lindhal P, Honkanen V, Lahdenne P, Kotaniemi K: Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2007, 66: 548-550.","journal-title":"Ann Rheum Dis"},{"key":"981_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaapos.2008.08.007","volume":"12","author":"I Tugal-Tutkun","year":"2008","unstructured":"Tugal-Tutkun I, Ayranci O, Kasapcopur O, Kir N: Retrospective analysis of children with uveitis treated with infliximab. J AAPOS. 2008, 12: 611-613. 10.1016\/j.jaapos.2008.08.007.","journal-title":"J AAPOS"},{"key":"981_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ophtha.2006.01.005","volume":"113","author":"P Kahn","year":"2006","unstructured":"Kahn P, Weiss M, Imundo LF, Levy DM: Favourable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology. 2006, 113: 860-864. 10.1016\/j.ophtha.2006.01.005.","journal-title":"Ophthalmology"},{"key":"981_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/bjo.2006.108050","volume":"91","author":"AM Mansour","year":"2007","unstructured":"Mansour AM: Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007, 91: 274-276. 10.1136\/bjo.2006.108050.","journal-title":"Br J Ophthalmol"},{"key":"981_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/OPTH.S23646","volume":"5","author":"K Kaisu Kotaniemi","year":"2011","unstructured":"Kaisu Kotaniemi K, S\u00e4il\u00e4 H, Kautiainen H: Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis. Clin Ophthalmol. 2011, 5: 1425-1429.","journal-title":"Clin Ophthalmol"},{"key":"981_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/acr.20404","volume":"63","author":"G Simonini","year":"2011","unstructured":"Simonini G, Taddio A, Cattalini M: Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. 2011, 63: 612-618. 10.1002\/acr.20404.","journal-title":"Arthritis Care Res"},{"key":"981_CR18","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/rheumatology\/ken298","volume":"47","author":"G Simonini","year":"2008","unstructured":"Simonini G, Zannin ME, Caputo R: Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. Rheumatology. 2008, 47: 1510-1514. 10.1093\/rheumatology\/ken298.","journal-title":"Rheumatology"},{"key":"981_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussemblatt RB, Rosembaum JT, and the Standardization of Uveitis Nomenclature (SUN) Working Group: Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop. Am J Ophthalmol. 2005, 140: 509-516.","journal-title":"Am J Ophthalmol"},{"key":"981_CR20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.ajo.2004.12.009","volume":"139","author":"DA Jabs","year":"2005","unstructured":"Jabs DA: Improving the reporting of clinical case series. Am J Ophthalmol. 2005, 139: 900-905. 10.1016\/j.ajo.2004.12.009.","journal-title":"Am J Ophthalmol"},{"key":"981_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3758\/BF03203630","volume":"28","author":"E Erdfelder","year":"1996","unstructured":"Erdfelder E, Faul F, Buchner A: GPower. A general power analysis program. Behav Res Meth Instrum Comput. 1996, 28: 1-11. 10.3758\/BF03203630.","journal-title":"Behav Res Meth Instrum Comput"},{"key":"981_CR22","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J: Statistical power analysis for the behavioral sciences. 1988, Hillsdale, NJ: Lawrence Erlbaum Associates, 2","edition":"2"},{"key":"981_CR23","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/eye.2009.203","volume":"23","author":"N Dhingra","year":"2009","unstructured":"Dhingra N, Morgan J, Dick AD: Switching biologic agents for uveitis. Eye. 2009, 23: 1868-1870. 10.1038\/eye.2009.203.","journal-title":"Eye"},{"key":"981_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deute C, Michels H: Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007, 91: 319-324. 10.1136\/bjo.2006.103721.","journal-title":"Br J Ophthalmol"},{"key":"981_CR25","first-page":"s100","volume":"62","author":"G Simonini","year":"2010","unstructured":"Simonini G, De Libero C, Caputo R: Use of Abatacept for childhood refractory vision-threatening uveitis [abstract]. Arthritis Rheum. 2010, 62: s100-","journal-title":"Arthritis Rheum"},{"key":"981_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/acr.20115","volume":"62","author":"F Zulian","year":"2010","unstructured":"Zulian F, Balzarin M, Falcini F: Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res. 2010, 62: 821-825. 10.1002\/acr.20115.","journal-title":"Arthritis Care Res"},{"key":"981_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","volume":"41","author":"D Wendling","year":"2011","unstructured":"Wendling D, Paccou P, Berthelot JM: New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases. Semin Arthritis Rheum. 2011, 41: 503-510. 10.1016\/j.semarthrit.2011.05.005.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-11-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1546-0096-11-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-11-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T12:01:47Z","timestamp":1548158507000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/1546-0096-11-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1186\/1546-0096-11-16","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"article-number":"16"}}